Skip to main content

Home/ Health and Fitness Club/ Group items tagged death

Rss Feed Group items tagged

pharmacybiz

Understanding UK Laws: Death, Wills, & Inheritance | Legal Guide - 0 views

  •  
    The topic of death is often a sensitive and somber one, but it is also a reality that we must face. When someone passes away, there are many legal considerations that come into play surrounding their assets, property, and final wishes. Before delving into the specifics, you must first understand that laws and regulations surrounding death and inheritance can vary greatly depending on location. Different countries, states, and even cities may have their own unique set of laws and procedures in place. involved. That's why you need a legal overview to guide you through the process of protecting your rights in the case of death. Wrongful Death Lawsuits and Compensation In the unfortunate event of a wrongful death, where a person dies due to the negligence or misconduct of another, the bereaved family may seek compensation through legal action. Hiring a lawyer for wrongful death is the best course of action to navigate the complex legal process and ensure that your rights are protected. Wrongful death lawsuits can cover a wide range of incidents, from car accidents to medical malpractice. The compensation awarded in these cases may include funeral expenses, lost wages, and loss of companionship. Know that each case is unique and the amount of compensation awarded will depend on the deceased's income and potential earnings, their age, and the extent of their financial support to their dependents.
pharmacybiz

England Faces Surge in Alcohol Deaths | Shocking Health Report 2024 - 0 views

  •  
    Public health experts are calling for a stronger, comprehensive government intervention to tackle the escalating levels of alcohol-related harm in England, as new data reveals a significant rise in alcohol deaths. Official figures indicate a "catastrophic rise" in alcohol-related deaths, with 8,274 people dying in 2023 alone-a 42% increase since 2019. Official figures indicate a "catastrophic rise" in deaths caused solely by alcohol, with 8,274 people dying in 2023 alone-a 42 per cent increase since 2019. The North East recorded the highest mortality rates, more than double those in London. The Alcohol Health Alliance (AHA), which represents 60 organisations working to reduce alcohol-related harm, has warned that this number represents only the tip of the iceberg as it reflects deaths wholly attributable to alcohol. When cases where alcohol was a contributing factor are considered, the death toll could triple the current estimates, they said.
pharmacybiz

Shocking: 14,000 Deaths in England from A&E Delays - 0 views

  •  
    In 2023, almost 14,000 people in England are estimated to have died due to excessive waits in emergency departments, averaging more than 260 deaths per week, according to new figures from the Royal College of Emergency Medicine (RCEM). The RCEM estimate is based on a large study of NHS patients published in the Emergency Medicine Journal in 2021, which found one excess death for every 72 patients who spent eight to 12 hours in an A&E department. Following a Freedom of Information audit of NHS trusts, the college has found that 65 per cent of people waiting 12 hours or more in A&E were patients waiting for a hospital bed. NHS data for England revealed that over 1.5 million patients waited 12 hours or more in major emergency departments last year. Based on the RCEM calculation, this indicates that over a million of those patients were waiting for a bed.
pharmacybiz

Tragic Death of Nurse Linked to Tirzepatide Weight-Loss Drug in Scotland - 0 views

  •  
    A 58-year-old nurse from North Lanarkshire, Scotland, has reportedly died after taking the weight-loss drug tirzepatide, which was recently approved for use on the NHS. Susan McGowan died from multiple organ failure, septic shock and pancreatitis, with the use of the Eli Lilly drug listed as a contributing factor on her death certificate, according to the BBC. She had taken two low-dose injections of tirzepatide, known by the brand name Mounjaro, over a two-week period before her death on 4 September. Her death is thought to be the first in the U.K. officially linked to the drug. McGowan, who had worked for over 30 years as a nurse at University Hospital Monklands in Airdrie, purchased a prescription for the drug through a registered online pharmacy. A few days after her second injection, McGowen began experiencing severe stomach pains and sickness. She went to A&E at Monklands - where her colleagues tried to save her life. Within days, her kidneys failed, and she fell into a coma as her other organs began to fail.
pharmacybiz

Mistakes at COVID testing lab may have led to deaths :UKHSA - 0 views

  •  
    The UK's Health Security Agency (UKHSA) said mistakes at a testing laboratory led to misreporting of tens of thousands of positive COVID-19 cases as negative and may have resulted in the deaths of about 20 people. Britain has one of the highest coronavirus death tolls in the world, with more than 177,000 deaths since the pandemic started in 2020. Many experts have said the contact tracing programme fell well short of the "world-beating" system the government had promised. An investigation by the government agency responsible for responding to public health emergencies said the Immensa laboratory in central England was found to have misreported around 39,000 tests as negative when they should have been positive between September 2 and October 12 last year.
pharmacybiz

Community Pharmacy : Role in Preventing CVD Deaths - 0 views

  •  
    Community pharmacies are well placed to play a role in preventing deaths from cardiovascular disease (CVD) said Director of NHS Services. The recent analysis by the British Heart Foundation (BHF) revealed that nearly 100,000 more people with cardiovascular disease than expected have died since the start of the pandemic in England. Latest figures show that the number of people waiting for time-sensitive cardiac care was at a record high of nearly 390,000 at the end of April in England. Average ambulance response times for heart attacks and strokes have consistently been above 30 minutes since the beginning of 2022, and in December 2022 they even breached 90 minutes. The target is 18 minutes, though the Government has set a new average target of 30 minutes over 2023/24. Director of NHS Services, Alastair Buxton, said: "It is concerning to hear that there have been tens of thousands of preventable deaths from cardiovascular disease (CVD) since the start of the COVID-19 pandemic. We share BHF's desire to see more action on preventing the causes of CVD and, subject to appropriate funding being in place, community pharmacy teams are well placed to play a role in this.
pharmacybiz

Scottish Drug Taskforce report:Role of community pharmacy - 0 views

  •  
    The Taskforce report recognises the important role of community pharmacy and pharmacy teams, and in particular, the fact that they often have most contact with individuals who are receiving medication assisted treatment, commented the Royal Pharmaceutical Society (RPS) on the publication of the Scottish Drug Deaths Taskforce's final report. The final report published on Thursday (June 21) follows four years of work developing and implementing a programme of actions to tackle the rising number of drug deaths in Scotland. RPS, as pharmacy's professional leadership body in Scotland and the rest of Great Britain, has positively engaged with the Taskforce as it carried out its work. Last year, RPS published 'Pharmacy's role in reducing harm and preventing drugs deaths (Scotland)' which contained 14 key recommendations. Many of the recommended actions within the Taskforce's report align with RPS policy.
pharmacybiz

Unveiling NHS Crisis:112 Lives Lost,8k Harmed in Care Delays - 0 views

  •  
    Long waits for an ambulance or surgery led to the death of 112 people, and nearly 8,000 more people suffered harm while waiting for help in England last year. The data from NHS England, obtained by The Guardian, show that patient deaths arising directly from care delays have risen more than fivefold over the last three years. In 2019, there were 21 patient deaths due to NHS care delays, and 96 people suffered "severe harm" as compared to 152 last year. Adult mental health care was mostly affected with 471 patients experiencing harm due to delays, followed by childbirth care (253), eye problems (221), and trauma and general surgery (207). There has been increase of 97 percent in the overall number of people suffering some degree of harm, from 3,979 in 2019 to 7,856 in 2022.
pharmacybiz

Nearly 150,000 Died on NHS Waiting Lists in England - Labour Analysis - 0 views

  •  
    A Labour Party analysis of NHS trust figures has revealed that around 148,000 people died last year while waiting for treatment in England. This is more than double the figure recorded in 2017/18, which stood at around 60,000 deaths. It even surpasses the mortality rate observed in 2021, during the peak of the Covid pandemic. The Labour Party obtained the data through a freedom of information request sent to every NHS trust in England. Out of the 169 acute and community trusts contacted, 80 responded. The total number of deaths reported by the respondents was 61,396. Extrapolating this figure to all trusts would suggest a total of 148,227 deaths.
michealfredinand

we are here to health out with some health issues like back pain, glucomis, insomia, gi... - 0 views

pharmacybiz

AMR research : Government allocates £39 million - 0 views

  •  
    The government has launched the Global AMR Innovation Fund (GAMRIF) on Monday (22 May), under which it has announce up to £39 million fund for antimicrobial resistance (AMR) research. Of this new funding package, up to £24 million over four years has been awarded to bolster the UK's partnership with CARB-X - a global AMR research initiative - to support the continued early development of invaluable new antibiotics, vaccines, rapid diagnostics and other products to combat life threatening drug-resistant infections and prevent death and disease across the world. In addition to the CARB-X grant, GAMRIF is investing £5 million over two years into the Global Antibiotic R&D Partnership (GARDP) to develop - and ensure global access to - new antibiotic treatments against major global health priorities. The announcement comes as Health Minister Will Quince attends the World Health Assembly (WHA) in Geneva, Switzerland, and Development Minister Andrew Mitchell participates in an event on health leadership and climate change alongside the WHA. They will announce the launch of the UK government's Global Health Framework for 2023-2025, as part of Minister Quince's address at the WHA. Health Minister Will Quince said: Antimicrobial resistance is a major threat to global health and has led to millions of tragic deaths per year, but the Global AMR Innovation Fund is supporting cutting-edge research and developing vital new treatments to prevent death and disease across the world.
pharmacybiz

India makes tests mandatory for cough syrup export - 0 views

  •  
    India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked to the deaths of dozens of children in Gambia and Uzbekistan. Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice dated May 22 and shared by the health ministry on Tuesday. India's $41 billion pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies. Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year. "Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," said the notice issued by the trade ministry. The health ministry did not immediately respond to a query on whether testing would be required for cough syrups sold in the domestic market.
pharmacybiz

Save Lives with Naloxone Kits in Scotland - 0 views

  •  
    Scottish community pharmacies will now hold two Naloxone kits, available in either nasal spray or injectable form, essential for reversing opioid overdoses. The Emergency Access Naloxone Scheme, which is backed by £300,000 of Scottish Government funding, began on Monday (30 October). Drugs and Alcohol Policy Minister Elena Whitham said, "Through our National Mission to reduce drug deaths and harms, we have invested more than £3 million in widening access to Naloxone, including through our emergency services." Witham said this new nationwide service is a welcome addition to existing services. "Police Scotland recently completed a force-wide rollout to 12,500 officers who have used the kits more than 300 times. According to the most recent statistics, 70 per cent of those who are at risk of opioid overdose are being provided with a lifesaving kit," she added. "It provides a substantial increase in life-saving emergency access and I'm grateful to all those in community pharmacies who are supporting our £250 million National Mission to reduce drug deaths," Whitham said.
pharmacybiz

Omicron subvariants spread:Risk of Covid deaths rising-ECDC - 0 views

  •  
    Two new subvariants of Omicron - BA.4 and BA.5 - are spreading much faster than other corovanirus variants in Europe, which could lead to more hospitalisations and deaths as they become dominant, the EU's disease prevention agency said on Monday (June 13). Most EU countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen - such as Portugal, where BA.5 accounted for 87 per cent of cases by May 30 - there have been surges in overall cases, according to the European Centre for Disease Prevention and Control (ECDC). The two sublineages were added to the World Health Organization's monitoring list in March and have also been designated as variants of concern by the ECDC. Variants BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron.But an increase in case numbers from higher transmission rates risks leading to an increase in hospitalisations and deaths, the agency said. "The growth advantage reported for BA.4 and BA.5 suggest that these variants will become dominant," ECDC said in a statement on its website.
pharmacybiz

Hepatitis C : UKHSA reports 35 per cent fall in deaths - 0 views

  •  
    Deaths caused by hepatitis C has declined by 35 per cent in England between 2015 and 2020, latest data from the UK Health Security Agency (UKHSA) revealed. It showed that estimated prevalence of chronic hepatitis C in England has continued to fall to around 81,000 in 2020 from 129,000 in 2015, showing a considerable progress has been made towards eliminating the virus as a public health problem by 2030 in England. Commenting on the data release, health and social care secretary Sajid Javid, said: "It is fantastic to see the significant progress that has been made in eliminating hepatitis C in England. Deaths and prevalence of the virus have fallen consistently thanks to improvements in diagnosis, access to treatments and the hard work of the NHS. "This is another example of the UK being at the forefront of tackling serious diseases. We are on track to eliminate this virus by 2030 and I urge anyone who may be at risk to get tested as soon as possible."
pharmacybiz

Breaking : Whooping Cough Outbreak in England - 9 Infant Deaths - 0 views

  •  
    A total of 7,599 whooping cough cases have been recorded in England from January to May 2024, according to new data released by the UK Health Security Agency (UKHSA). In January 2024, there were 555 cases, followed by 920 in February, 1,427 in March, 2,106 in April, and 2,591 in May. While the majority of cases (over 53 per cent) occurred in individuals aged 15 years or older, who typically experience milder symptoms, a significant number (262) were reported in babies under 3 months old, who are at the highest risk of severe complications and death from whooping cough. Since the outbreak began in November last year, there have been nine infant deaths (one in December 2023 and eight between January and May 2024). Whooping cough, or pertussis, is a bacterial infection affecting the lungs. This cyclical disease peaks every 3 to 5 years, with the last increase seen in 2016.
pharmacybiz

Act FAST for Stroke: NHS Urges 999 Calls as Stroke Patients Delay Emergency Action | UK... - 0 views

  •  
    NHS England has launched the first major update to the 'Act FAST' campaign since 2009, as new data reveals that many stroke patients wait almost an hour and a half on average before making an emergency call. The updated campaign urges the public to call 999 immediately if anyone experiences one of the three common stroke symptoms: difficulty smiling (Face), trouble raising an arm (Arms), or slurred speech (Speech). Around 100,000 people are estimated to suffer a stroke each year in the UK, which occurs when the blood supply to part of the brain is cut off. Without prompt treatment, a stroke can lead to death or long-term disabilities such as paralysis, memory loss and communication problems. Strokes remain the fourth single leading cause of death in the UK, resulting in about 38,000 deaths each year. An analysis of NHS data for 2023-24 indicated that among 41,327 patients with a recorded time of symptom onset, the average time from the first symptom to making a 999 call was 88 minutes. Additionally, a poll of 2,001 adults in England revealed that 57 per cent of respondents believed you should have 2-3 symptoms of a stroke before calling 999, despite the fact that even one symptom is a sign of a medical emergency.
pharmacybiz

World's first ovarian cancer vaccine: University of Oxford awarded £600,000 f... - 0 views

  •  
    Researchers at the University of Oxford have received a grant of up to £600,000 from Cancer Research UK to develop the world's first vaccine to prevent ovarian cancer. Named OvarianVax, the innovative vaccine aims to train the immune system to recognise and attack the earliest stages of ovarian cancer. Ovarian cancer is the sixth most common cancer among women in the UK, with approximately 7,500 new cases diagnosed annually-equating to about 21 cases each day. It is also a leading cause of cancer-related deaths in women, with around 4,100 deaths each year, accounting for five per cent of all cancer deaths in UK females. Projections suggest that by 2038-2040, there could be around 9,400 new cases of ovarian cancer annually in the UK. Several factors influence a person's risk of developing ovarian cancer, including age, genetics, hormone replacement therapy (HRT), smoking, asbestos exposure, medical conditions such as endometriosis or diabetes, and obesity. Faults in the inherited genes, particularly BRCA1 and BRCA2, are linked to a higher risk of ovarian cancer, contributing to 5-15 per cent of cases.
pharmacybiz

Unlock Dementia Care Solutions - Free Webinar for UK Healthcare Professionals | Nov 2024 - 0 views

  •  
    Dementia and Alzheimer's disease remained the leading cause of death in England and Wales in 2023, maintaining the pre-pandemic trend, according to the latest data from the Office for National Statistics (ONS). The figures reveal that there were 66,876 deaths with an underlying cause of dementia and Alzheimer's disease, accounting for 11.6% of all deaths registered that year. In response to this growing health concern, Luye Pharma is hosting a free special educational webinar on 6 November 2024 (timing: 18:30 - 20:00) for healthcare professionals. Titled "Treating Dementia in 2024: Optimising Pathways Between Primary and Secondary Care," the online session will focus on addressing the ever-increasing challenges in dementia treatment and how to optimise pathways between primary and secondary care. The webinar will feature expert speakers from the field of dementia care, including Dr. Jill Rasmussen, Primary Care Specialist in dementia, mental health, and intellectual disabilities; Delia Bashara, Consultant Pharmacist for the Mental Health of Older Adults and Dementia at South London and Maudsley NHS Foundation Trust; and Khaleel Loonat, Senior Clinical Pharmacist and Advanced Clinical Practitioner.
pharmacybiz

Queen Elizabeth II: Community pharmacy deeply saddened - 0 views

  •  
    Queen Elizabeth II, Britain's longest-reigning monarch, the nation's figurehead and a towering presence on the world stage for seven decades, died peacefully at her home in Scotland on Thursday aged 96. "The death of my beloved Mother, Her Majesty The Queen, is a moment of the greatest sadness for me and all members of my family," the new king, her eldest son Charles, said. "I know her loss will be deeply felt throughout the country, the Realms and the Commonwealth, and by countless people around the world," the 73-year-old said in a statement. The news has stunned and deeply saddened community pharmacy in Britain. The Pharmaceutical Services Negotiating Committee (PSNC) issued a statement to say it "has been very saddened to hear of the death of Her Majesty the Queen. "At this time of national mourning, we join the rest of the country in sending our thoughts and condolences to the royal family."
1 - 20 of 115 Next › Last »
Showing 20 items per page